Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 9708386 Modified chimeric polypeptides with improved pharmacokinetic properties

Patent 9708386 was granted and assigned to Regeneron Pharmaceuticals on July, 2017 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 2 Oct, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 2 Oct, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12103960 VEGF traps and mini-traps and methods for treating ocular disorders and cancer
0
Edits on 4 Sep, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 4 Sep, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12077570 Anti-VEGF protein compositions and methods for producing the same
0
Edits on 7 Aug, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 7 Aug, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
0
"update inverses"
Golden AI profile picture
Golden AI
edited on 7 Aug, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
0
Edits on 19 Jun, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 19 Jun, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12012444 Anti-VEGF protein compositions and methods for producing the same
0
Edits on 12 Jun, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 12 Jun, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12005097 Aflibercept formulations and uses thereof
0
Edits on 6 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 6 Dec, 2023
Edits made to:
Article (+322 characters)
Article

Patent abstract

The present invention provides VEGF antagonists with improved pharmacokinetic properties. According to certain embodiments, a fusion polypeptide capable of antagonizing VEGF activity is provided comprising a modified extracellular ligand binding domain of a VEGF receptor fused to a multimerizing component.

Edits on 13 Sep, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 13 Sep, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11753459 Anti-VEGF protein compositions and methods for producing the same
Edits on 22 Jul, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 22 Jul, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=0970838600
Edits on 19 May, 2023
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 19 May, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent 09708386 Modified chimeric polypeptides with improved pharmacokinetic properties US Patent 9708386 Modified chimeric polypeptides with improved pharmacokinetic properties

Infobox
Patent Number
0970838600
Patent Number
970838600
Edits on 22 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 22 Apr, 2023
Infobox
Is a
Patent
Patent
0
Patent Applicant
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
0
Current Assignee
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
097083860
Date of Patent
July 18, 2017
0
Patent Application Number
148229290
Date Filed
August 11, 2015
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=097083860
Patent Primary Examiner
‌
Christine J. Saoud
0
Edits on 25 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 25 Sep, 2022
Infobox
Is a
Patent
Patent
0
Patent Applicant
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
0
Current Assignee
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
097083860
Date of Patent
July 18, 2017
0
Patent Application Number
148229290
Date Filed
August 11, 2015
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=097083860
Patent Primary Examiner
‌
Christine J. Saoud
0
Edits on 15 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 15 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=09708386
Edits on 13 Jan, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 13 Jan, 2022
Edits made to:
Infobox (+9 properties)
‌

 US Patent 09708386 Modified chimeric polypeptides with improved pharmacokinetic properties

Infobox
Is a
Patent
Patent
Patent applicant
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
Current assignee
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
09708386
Date of patent
July 18, 2017
Patent application number
14822929
Date Filed
August 11, 2015
Patent primary examiner
‌
Christine J. Saoud

Find more entities like US Patent 9708386 Modified chimeric polypeptides with improved pharmacokinetic properties

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo